CIM-3D

N/A

Report date: 2025/01/26 18:27:38

NME

Base Information

Drug NameCIM-3D

Drug Alias NameENPP1 inhibitors (CISTIM/KU Leuven)small-molecule inhibitors of ectonucleotide pyrophosphatase phosphodiesterase 1 (Center for Innovation and Stimulation of Drug Discovery/KU Leuven)CIM-3D

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEctonucleotide Pyrophosphatase/Phosphodiesterase 1 inhibitors

TargetsEctonucleotide Pyrophosphatase/Phosphodiesterase 1

Therapy Area/IndicationsTriple Negative Breast NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKu Leuven

China Registration ClassN/A

Develop Information

Active CompaniesCenter for Innovation and Stimulation of Drug Discovery Ku Leuven

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast Neoplasms

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A